IMPDH2 and mycophenolic acid:: Effect of a novel SNP on enzyme activity and leukopenia in transplant patients.

被引：0
|
作者：
Wang, J.
Zeevi, A.
Webber, S.
Gimita, M.
Selby, R.
Sher, L.
Fu, J.
Phougsamran, P.
Pravica, V.
Hutchinson, I. V.
Burckart, G. J.
机构：
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
113
引用
收藏
页码：1088 / 1088
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic modeling of the effect of mycophenolic acid exposure on inosine monophosphate dehydrogenase activity in pediatric kidney transplant patients
    Thogersen, Havard
    Goebel, Jens
    Cox, Shareen
    Maseck, Denise
    Logan, Barbara
    Vinks, Alexander A.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 480 - 480
  • [22] Measurement of circulatory unhydrolysed mycophenolate mofetil (MMF) to mycophenolic acid (MPA) with intravenous MMF in post liver transplant patients.
    Jain, Ashok
    Mohanka, Ravi
    Tai, Kwong
    Orloff, Mark
    Abt, Peter
    Bozorgzadeh, Adel
    LIVER TRANSPLANTATION, 2006, 12 (05) : C125 - C125
  • [23] Effect of rapamycin on free fatty acid metabolism in renal transplant patients.
    Morrisett, JD
    Hoogeveen, RC
    Abdel-Fattah, G
    Pownall, HJ
    Ballantyne, CM
    Opekun, AR
    Jaffe, JS
    Oppermann, S
    Kahan, BD
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 654 - 654
  • [24] Impdh activity is correlated with the 3757T>C polymorphism in the IMPDH type 2 gene in MMF treated kidney transplant patients
    Sombogaard, F.
    van Schaik, R. H.
    Mathot, R. A. A.
    Budde, K.
    van der Werf, M.
    Vulto, A. G.
    Weimar, W.
    Glander, P.
    Essioux, L.
    van Gelder, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 134 - 134
  • [25] IMPDH activity is correlated with the 3757T>C polymorphism in the IMPDH type 2 gene in MMF treated kidney transplant patients
    Sombogaard, F.
    van Schaik, R.
    Mathot, R.
    Budde, K.
    van der Werf, M.
    Vulto, A.
    Weimar, W.
    Glander, P.
    Essioux, L.
    van Gelder, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 515 - 515
  • [26] High Dose Mycophenolic Acid (MPA) Results in Reduction or Stabilization of Donor Specific HLA Antibodies (DSA) in Kidney Transplant Patients.
    Rebellato, L.
    Bolin, P.
    Ozawa, M.
    Parker, K.
    Briley, K.
    Catrou, P.
    Ward, R.
    Everly, M.
    Haisch, C.
    Terasaki, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 296 - 297
  • [27] Comparison of HPLC with the EMIT assay from Dade Behring for determination of Mycophenolic acid levels in plasma from renal transplant patients.
    Pawinski, T
    Majchrzak, J
    Gralak, B
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 503 - 503
  • [28] Limited sampling strategy for estimation of mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplant (HCT) patients.
    Ng, JW
    Rogosheske, J
    Jacobson, P
    PHARMACOTHERAPY, 2004, 24 (10): : 1466 - 1466
  • [29] Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels
    van Besouw, NM
    van der Mast, BJ
    Gregoor, PJHS
    Hesse, CJ
    IJzermans, JNM
    van Gelder, T
    Weimar, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2710 - 2713
  • [30] Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil
    Jain, AB
    Hamad, I
    Zuckerman, S
    Zhang, SM
    Warty, VS
    Fung, JJ
    Venkataramanan, R
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (02): : 101 - 106
12345